SEC Filings

 
SEC Filings
Date Filing Description View
Feb 14, 2005 SC 13G statement of beneficial ownership HTML PDF XLS
54.6 KB
Add to Briefcase
Feb 11, 2005 SC 13G statement of beneficial ownership HTML PDF XLS
27.4 KB
Add to Briefcase
Feb 4, 2005 8-K current report HTML PDF XLS
33.9 KB
Add to Briefcase
Nov 17, 2004 10-Q quarterly report HTML PDF XLS
615.4 KB
Add to Briefcase
Nov 3, 2004 8-K current report HTML PDF XLS
73.9 KB
Add to Briefcase
Oct 25, 2004 REGDEX form regdex HTML
0.0 KB
Oct 12, 2004 4 glaxosmithkline, plc HTML PDF XLS
34.8 KB
Add to Briefcase
Oct 8, 2004 8-K current report HTML PDF XLS
32.7 KB
Add to Briefcase
Oct 7, 2004 4 sturmer, a gregory HTML PDF XLS
33.4 KB
Add to Briefcase
Oct 7, 2004 4 glick, marty HTML PDF XLS
32.1 KB
Add to Briefcase
FirstPrevious
...
116
...
NextLast
= add PDF file to Briefcase

Innoviva NASDAQ: INVA

$14.39 0.14 (0.93%) 01/18/18 3:55 PM ET Refresh Quote

Data provided by Nasdaq.
Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.